Ledger.Open graph →
SEC Form D · filed July 23, 2014

Faraday Pharmaceuticals, Inc

Offering
$6.5M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Robert Nelsen · Seattle, WADirectorRobert Nelsen · Hampton, NJDirectorMark Roth · Upper Saddle River, NJExec · Director · PromoterSteven Gillis · Chicago, ILExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗